Synthetic peptide vaccine against Taenia solium pig cysticercosis: Successful vaccination in a controlled field trial in rural Mexico

Vaccine

Volumn 20, Issue 1-2, 2001, Pages 262-266

  Huerta, M ^b   De Aluja, A S ^a   Fragoso, G ^a   Toledo, A ^a   Villalobos, N ^a   Hernandez M ^a   Gevorkian, G ^a   Acero, G ^a   Diaz A ^b   Alvarez, I ^b   Avila, R ^b   Beltran C ^a   Garcia, G ^a   Martinez, J J ^a   Larralde, C ^a   Sciutto, E ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

Author keywords

Cysticercosis; Synthetic peptides; Vaccines

Indexed keywords

ALANYLPROLYLMETHIONYLSERYLTHREONYLPROLYLSERYLALANYLTHREONYLSERYLVALYLARGINY LGLYCINE; GLYCYLASPARGYLLEUCYLLEUCYLLEUCYLSERYLCYSTYLLEUCYLGLYCINE; GLYCYLTYROSYLTYROSYLTYROSYLPROLYLSERYLASPARTYLPROLYLASPARAGINYLTHREONYLPHEN YLALANYLTHREONYLALANYLPROLYLPROLYLTYROSYLSERYLALANINE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; VACCINE;

AMINO ACID SEQUENCE; ARTICLE; AUTOPSY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CYSTICERCOSIS; EVALUATION; MEXICO; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RURAL AREA; SWINE; TAENIA SOLIUM; VACCINATION;

AMINO ACID SEQUENCE; ANIMALS; CYSTICERCOSIS; ENVIRONMENTAL EXPOSURE; FEMALE; MEXICO; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PILOT PROJECTS; PREGNANCY; PREVALENCE; RURAL HEALTH; SWINE; SWINE DISEASES; TAENIA; VACCINATION; VACCINES; VACCINES, SUBUNIT; ZOONOSES;

EID: 0035850960     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00249-3     Document Type: Article

References (31)

1. Taenia solium disease of humans and pigs: An ancient parasitic disease rooted in developing countries and emerging as a major health problem of global dimensions
2. Brain cysticercosis
3. Neurocysticercosis: Updates on epidemiology, pathogenesis, diagnosis, and management
4. Neurocysticercosis among children in Chicago
5. Immigrants, imaging, and immunoblots: The emergence of neurocysticercosis as a major public health problem
6. Neurocysticercosis in Spain. Approximately four cases seen in immigrant patients from endemic countries
7. Eradication of Taenia solium cysticercosis: Role for vaccination of pigs
8. Vaccination trial against Taiwan Taenia eggs in pigs injected with frozen oncospheres of Taiwan Taenia, Kores Taenia, T. saginata or T. solium
9. Vaccination against ovine cysticercosis using a defined recombinant antigen
10. Immunization of pigs against the cysticercus of Taenia solium using fractionated first and second peaks of cysticercus cellulosae scolex antigen
11. Immunization of pigs with culture antigens of Taenia solium
12. Effective immune protection of pigs against cysticercosis
13. Vaccination against Taenia solium cysticercosis in pigs using native and recombinant oncosphere antigens
14. Immunization against porcine cysticercosis in an endemic area in Mexico: A field and laboratory study
15. Field trial for reducing porcine Taenia solium cysticercosis in Mexico by systematic vaccination of pigs
16. Deciphering western blots of tapeworm antigens (Taenia solium, Echinococcus granulosus, and Taenia crassiceps) reacting with sera from neurocysticercosis and hydatid disease patients
17. Analysis of antigenic variation in cysticerci of Taenia solium
18. Immunization against Taenia crassiceps cysticercosis: Identification of the most promising antigens in the induction of protective immunity
19. Immunization of pigs against Taenia solium cysticercosis: Factors related to effective protection
20. Cysticercosis: Identification and cloning of protective recombinant antigens
21. Studies on the biology of Taenia crassiceps (Zeder, 1800) Rudolphi, 1810 (Cestoda)
22. Cysticercosis vaccine: Cross protecting immunity with Taenia solium antigens against experimental murine Taenia crassiceps cysticercosis
23. Taenia crassiceps cysticercosis humoral immune response and protection elicited by DNA immunization
24. Taenia crassiceps cysticercosis: Protective effect and immune response elicited by DNA immunization
25. Towards a Taenia solium cysticercosis vaccine: An epitope shared by Taenia crassiceps and Taenia solium protects mice against experimental cysticercosis
26. Two epitopes shared by Taenia crassiceps and Taenia solium confer protection against murine cysticercosis along with prominent T1 response
27. Taenia solium cysticercosis in young pigs: Age at first infection and histological characteristics
28. Randomized, controlled trials, observational studies, and the hierarchy of research designs
29. Increased resistance to Taenia crassiceps murine cysticercosis in Qa-2 transgenic mice
30. Shift from an early protective Th1-type immune response to a late permissive Th2-type response in murine cysticercosis (Taenia crassiceps)
31. Vaccination against Taenia solium cysticercosis in underfed rustic pigs of México: Roles of age, genetic background and antibody response